33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.07%
Net income growth similar to MDB's 22.08%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
-1.70%
Negative yoy D&A while MDB is 7.91%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
0.23%
Less SBC growth vs. MDB's 2.22%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-229.04%
Negative yoy working capital usage while MDB is 55.13%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
79.06%
AR growth well above MDB's 99.35%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-150.17%
Negative yoy inventory while MDB is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
54.60%
Lower AP growth vs. MDB's 2857.69%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-178.69%
Both reduce yoy usage, with MDB at -21.23%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
210.38%
Some yoy increase while MDB is negative at -21.16%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
54.00%
Operating cash flow growth below 50% of MDB's 251.85%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-11.68%
Both yoy lines negative, with MDB at -227.24%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
8.24%
Purchases well above MDB's 0.22%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
0.43%
We have some liquidation growth while MDB is negative at -8.42%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
3906.00%
Growth of 3906.00% while MDB is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
91.39%
We have mild expansions while MDB is negative at -50.03%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-7.28%
Both yoy lines negative, with MDB at -1.40%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-97.96%
Negative yoy issuance while MDB is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.